Big Ideas 2026: Multiomics
As multiomics moves beyond bulk genomics into single‑cell, spatial, and multimodal approaches, demand for instruments, consumables, and automation should rise. This play focuses on the infrastructure and toolmakers—‘picks and shovels’—that enable greater data generation and analysis across research and clinical workflows.
Linked assets
Featured tickers: TXG (10x Genomics) — single‑cell and spatial genomics tools; TMO (Thermo Fisher Scientific) — broad life‑science tools, consumables, and lab automation; PACB (Pacific Biosciences) — long‑read sequencing with upside if long reads gain share; ILMN (Illumina) — incumbent sequencing provider that could benefit from higher clinical volumes but faces disruption risk.
TXG is 10x Genomics, Inc., a Healthcare equity in Health Information Services, developing tools and consumables for single-cell and spatial genomics research.
Direct exposure to single-cell/spatial multiomics workflows as labs expand beyond bulk genomics.
TMO is Thermo Fisher Scientific Inc, a Healthcare equity in the Diagnostics & Research industry.
Broadest diversified exposure across life-science tools/consumables and lab automation supporting multiomics scale-up.
PACB is an equity of Pacific Biosciences of Californ, a Healthcare sector company in the Medical Devices industry.
Potential share gains if richer long-read data becomes a larger component of multiomic pipelines; higher execution risk.
Illumina, Inc.
Could benefit from higher clinical volumes, but faces disruption/price pressure if long-read/alternative technologies gain share.
Source proof
Source proof: Strong source proof | 4 directional assets | 1 supporting author | headline-like title review
Related source materials include ARK’s Big Ideas 2026 segments on multiomics-adjacent themes (AI Productivity, Bitcoin) and a mix of podcast/video entries. Several items were non-substantive or outside finance; relevant research notes were used to inform the play thesis where available.
Transcript-style snippet discussing competition among AI model providers (Kimi K3, OpenAI, Anthropic, Grok), uncertainty about API economics/margins, and implications for AI infrastructure and enterprise software. The only explicit tradable tickers mentioned are AMD and CRM. Overall, the content is low-specificity and not strongly actionable (no clear catalyst, timing, or quantified claims).
Fragmentary excerpt referencing ARK Big Ideas 2026 focused on DeFi applications; only explicit assets mentioned are Bitcoin and Ethereum, with unclear/partial statements about revenue and revenue per employee. Limited concrete catalysts, metrics, or trade setup details are provided in the text.
Discussion about Lucra (private company) selling an SDK to help brands “gamify” loyalty/engagement via QR-code-driven, shorter interactive experiences; claims of expanding TAM and interest from large partners (mentions PGA/UK partner context). No concrete financials, dates, contracts, or public-company catalysts are provided.
Discussion suggests AI model economics are shifting toward owning infrastructure vs paying cloud markups; cloud providers earn ~50% gross margin, while model/API players (e.g., xAI/Grok) may gain marginal API share via cost iteration and positioning. Content is fragmentary and not tied to a concrete catalyst.
ARK-style bullish narrative on AMD: large AI compute TAM, strong server CPU share gains vs Intel, expanding GPU/AI accelerator opportunity, leveraging TSMC fabless model and hyperscaler adoption (AWS noted). Mentions competitive pressure (implicitly NVIDIA in AI, Intel in CPUs) but overall framing is bullish AMD.
Podcast-style discussion covering (1) Tesla’s Model Y L and implications for family demand + robotaxi/FSD strategy, (2) a claimed Rocket Lab–Iridium acquisition and broader satellite bandwidth/launch-capacity constraints, and (3) frontier AI models and open-source vs closed ecosystems. The source is high-level with limited concrete, time-bound catalysts; actionability is moderate-low except for the space/launch-capacity theme (if corroborated) and continued Tesla product/FSD narrative.
The source claims SpaceX believes “90%+ of its future market is AI,” framing an “AI master plan” centered on orbital data centers and a massive TAM. SpaceX is private, and the piece provides no concrete timelines, contracts, capex numbers, counterparties, or regulatory milestones—so direct trading action is limited. Actionability is mainly thematic (space connectivity + edge/orbital compute + launch cadence) via public proxies: AI compute supply chain, satellite operators, and space launch/space systems comps.
The provided source contains only a title (“Big Ideas 2026: Autonomous Logistics”) and no substantive body content. There are no stated catalysts, claims, data, company mentions, or tradeable implications to extract.
Supporting authors
This play was prepared by ARK research analysts synthesizing public episodes, presentations, and internal Big Ideas 2026 materials. Author count: 1.
Unlock full thesis monitoring
For a deeper read, download or view the full Big Ideas 2026 report and model to assess how multiomics infrastructure exposure fits within diversified portfolio strategies.